who should not take glp-1 receptor agonists Frontiers GLP-1 Medications 💊 Who should

Almasio P, Bortolini M, Pagliaro L, Coltorti M

Sciatica: review of epidemiological studies and prevalence estimates

1-6 Secondary carnitine deficiency can be a consequence of inborn errors of metabolism or iatrogenic factors such as hemodialysis

For practical comparison: | Property | Native IGF-1 | IGF-1 DES | IGF-1 LR3 | |---|---|---|---| | Amino acids | 70 | 67 | 83 | | Half-life | ~10 min | ~20-30 min | ~20-30 h | | IGFBP-3 affinity | High | Low | Very low (~1,000x reduced) | | Relative IGF-1R potency | 1x | ~10x | ~2-3x | | Systemic vs

The practical value is better recovery, sleep, lean muscle support, and training consistency

It stimulates lipolysis (fat breakdown) and inhibits lipogenesis (fat accumulation)